6 15

Cited 0 times in

개방각 녹내장 환자에서 Xalatan®( 0.005% Latanoprost ) 병용 요법의 효과

Other Titles
 The Additive Effect of Xalatan®( 0.005% Latanoprost ) to Beta Adrenergic Receptor Blocker in Patients with Open Angle Glaucoma 
Authors
 이형근  ;  성공제 
Citation
 Journal of the Korean Ophthalmological Society (대한안과학회지), Vol.39(1) : 169-176, 1998 
Journal Title
 Journal of the Korean Ophthalmological Society (대한안과학회지) 
ISSN
 0378-6471 
Issue Date
1998
Abstract
The effect on intraocular pressure(IOP) and side effects of adding Xalatan(0.005% Latanoprost) to beta blockers was studied in 54 eyes of 33 patients with primary open angle glaucoma that was inadequately controlled with beta blocker alone. Routine eye physical examination and IOP measurement were performed before the additive therapy. Then, the Xalatan eye drops were topically applied once a day at 5:00 PM with previously used four kind of beta blockers. IOP measured at 1 week, 1 month, 2 month, and 3 month after the combined therapy. Mean IOP was 18.6±3.4mmHg before combined therapy. 14.3±3.5mmHg after 1 week, 1 treatment, 13.5±3.3mmHg after 1 month, 13.1±2.7mmHg after 2 months and 13.1±2.6mmHg after 3 months the therapy. Side effects of combined therapy were conjunctival hyperemia(24.1%), eyeball pain(11.1%), tearing(7.4%), headache(5.5%) and blurred vision(3.6%). There were not any cases of iris pigment change. These results indicate that adding Xalatan in patient treated with beta blocker cause a further reduction of IOP that may prove to be clinically useful in glaucoma therapy
Files in This Item:
T199801974.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers
Yonsei Authors
Seong, Gong Je(성공제) ORCID logo https://orcid.org/0000-0002-5456-4296
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/176669
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links